Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001415889-22-001515 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-15 | BDTX | Jones Erika | SEE REMARKS | A - Grant | $0.00 | +5,075 | 5,075 | New | $0 |
| D | 2022-02-17 | 2022-02-15 | BDTX | Jones Erika | SEE REMARKS | A - Grant | $0.00 | +20.3K | 20.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | A | A | 5,075 | $0.00 | 5,075 | D | — | — | (F1) Represents a grant of Restricted Stock Units ("RSUs") under the Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest as follows: 35% on the 9 month anniversary of February 15, 2022 (the "Vesting Commencement Date"), 35% on the 18 month anniversary of the Vesting Commencement Date, and the remaining 30% on the 27 month anniversary of the Vesting Commencement Date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-02-15 | A | A | 20,300 | $0.00 | 20,300 | D | $3.79 · — to 2032-02-14 | 20,300 Common Stock | (F2) 25% of the shares subject to this option shall vest and become exercisable on February 15, 2023, with the remainder vesting in 36 equal monthly installments thereafter. |